$5.44 2.6%
CDXC Stock Price vs. AI Score
Data gathered: December 24

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Chromadex

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services.


Chromadex
Price $5.44
Target Price Sign up
Volume 196,030
Market Cap $405M
Year Range $2.44 - $7.72
Dividend Yield 0%
PE Ratio 265
Analyst Rating 100% buy
Industry Fitness & Health

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2426M9.3M16M1.9M1.6M0.020
Q2 '2423M9M14M-15,000-220,0000.000
Q1 '2422M8.7M13M-500,000-690,000-0.010
Q4 '2321M8.3M13M160,000-130,0000.002
Q3 '2319M7.5M12M-960,000-1.1M-0.010

Insider Transactions View All

Jaksch Frank L Jr filed to sell 244,179 shares at $6.2.
December 13 '24
Pamir Ozan filed to buy 2,907 shares at $7.4.
November 25 '24
Dvorak International Ltd filed to buy 19,294,356 shares at $0.
August 21 '24

What is the Market Cap of Chromadex?

The Market Cap of Chromadex is $405M.

What is Chromadex's PE Ratio?

As of today, Chromadex's PE (Price to Earnings) ratio is 265.

What is the current stock price of Chromadex?

Currently, the price of one share of Chromadex stock is $5.44.

How can I analyze the CDXC stock price chart for investment decisions?

The CDXC stock price chart above provides a comprehensive visual representation of Chromadex's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Chromadex shares. Our platform offers an up-to-date CDXC stock price chart, along with technical data analysis and alternative data insights.

Does CDXC offer dividends to its shareholders?

As of our latest update, Chromadex (CDXC) does not offer dividends to its shareholders. Investors interested in Chromadex should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Chromadex?

Some of the similar stocks of Chromadex are Peloton, Planet Fitness, WW International, Academy Sports + Outdoors, and Herbalife Nutrition.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.